Related Experiment Video
Updated: Sep 7, 2025

07:52
Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
16.3K
Refractory Psychosis After Carbon Monoxide Poisoning: a Case Report.
C K W Wong1, M M Kwan1, W K Lam1
1Department of Psychiatry, Kowloon Hospital.
Summary
This case study details refractory psychosis following carbon monoxide poisoning. Clozapine showed symptom improvement in a patient with organic brain syndrome after other antipsychotics failed.
Area of Science:
- Neuroscience
- Psychiatry
- Toxicology
Background:
- Carbon monoxide (CO) poisoning can lead to severe neurological and psychiatric sequelae.
- Refractory psychosis presents a significant challenge in clinical management, often requiring extensive treatment trials.
Observation:
- A 65-year-old woman developed refractory psychosis, including paranoia and auditory hallucinations, after attempted suicide via charcoal burning (CO poisoning).
- Initial treatment with quetiapine, followed by olanzapine augmentation with amisulpride and valproate sodium, yielded poor clinical response.
- The patient remained significantly distressed and psychotic despite multiple antipsychotic trials.
Findings:
- Switching to clozapine (300 mg nightly) resulted in marked improvement of psychotic symptoms.
- While residual auditory hallucinations persisted, the patient experienced reduced distress associated with them.
Implications:
- Clozapine may be an effective treatment option for refractory psychosis secondary to carbon monoxide poisoning.
- This case highlights the complex neuropsychiatric manifestations of CO poisoning and the need for persistent therapeutic strategies.
- Further research into the neurobiological mechanisms underlying CO-induced psychosis and clozapine's efficacy is warranted.
Related Concept Videos
Acute Respiratory Failure-III
311
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
311
Acute Respiratory Failure-II
343
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
343
Acute Respiratory Failure-I
305
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
305
Acute Respiratory Failure-IV
218
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
218
Diagnosing Acidosis and Alkalosis
503
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
503
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K

